
Consensus of Chinese experts on diversified rehabilitation interventions for Alzheimer's disease (2025)
Nanbu WANG, Xiaowei MA, Guohui WANG, Hongzheng WANG, Yan XING, Ning ZHU, Liyan QIAO, Jin QIAO, Taojie LIU, Zhi LIU, Xiandong SUN, Xiaoxia DU, Jianping LI, Chenzhong LI, Yu YANG, Zhiquan YANG, Xia HE, Youqiang SONG, Liying ZHANG, Zhiguo ZHANG, Ruiping HU, Shan XU, Qi TANG, Chuanhai CAO, Yao CUI, Shaoyang CUI, Xiaole HAN, Jikang FAN, Chi CAO, Luping SONG, Jun WANG, Profssional Branch of the China Association for Alzheimer’s Disease Cognitive Rehabilitation
Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2025, Vol. 8 ›› Issue (3) : 147-163.
Abbreviation (ISO4): Chinese Journal of Alzheimer's Disease and Related Disorders
Editor in chief: Jun WANG
Consensus of Chinese experts on diversified rehabilitation interventions for Alzheimer's disease (2025)
To better address the severe challenges of Alzheimer's disease (AD) prevention and control in China, the national government has published the National Action Plan for Addressing the elderly people with dementia. In order to accelerate the achievement of its core objectives, the Chinese Expert Consensus on Multidisciplinary Rehabilitation Interventions for Alzheimer's Disease has been formulated by integrating multidisciplinary expert opinions and evidence-based findings, using the Delphi method combined with GRADE evidence grading. This consensus advocates a “hospital-community-family” tripartite collaborative management model to standardize systematic and multidimensional approaches for the prevention, treatment, rehabilitation, and care of AD.This consensus deliver evidence-based guidance for tripartite stakeholders (healthcare providers, community networks, and family care systems) to operationalize healthy aging strategies through standardized AD management protocols.. For preventive strategies, AD risk factors are categorized into low-, medium-, and high-risk tiers to guide the formulation of personalized prevention and intervention strategies. For therapeutic management, treatment regimens are stratified by AD clinical stages (mild/moderate/severe), incorporating Western pharmacotherapy, traditional Chinese medicine and neuromodulation techniques. Rehabilitation requires individualized protocols based on multidimensional assessments encompassing functional disability evaluations, personal preferences, and familial support systems, with active rehabilitation prioritized during early/mid-stages and passive interventions dominating advanced AD care. Rehabilitation measures include cognitive therapies (including cognitive training, cognitive stimulation, and cognitive rehabilitation), lifestyle modifications (featuring nutritional guidance and exercise regimens that combine aerobic, strength, and mind-body training), humanistic approaches (such as reminiscence and immersive technologies), art-based therapies (applying music, dance, and visual arts), nature-assisted therapies (through horticultural and animal-assisted interaction), as well as sensory modulation techniques (utilizing light therapy and aromatherapy). For moderate-to-advanced stage AD patients presenting with behavioral and psychological symptoms of dementia or profound cognitive-functional decline, care strategies should implement person-centered care frameworks to preserve self-identity, deliver integrated palliative support, and manage comorbidities through multidisciplinary coordination.
Alzheimer's disease / Diversified Interventions / Prevention / Treatment / Rehabilitation / Care
[1] |
|
[2] |
王刚, 齐金蕾, 刘馨雅, 等. 中国阿尔茨海默病报告2024[J]. 诊断学理论与实践, 2024, 23(3): 219-256.
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
蔡福果, 洪伟, 折宁宁, 等. 阻塞性睡眠呼吸暂停、肥胖与认知功能障碍研究进展[J]. 国际耳鼻咽喉头颈外科杂志, 2024, (4): 213-216.
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
周媛媛, 周香莲, 王杰, 等. 轻度认知功能障碍向痴呆进展的危险因素及保护因素研究[J]. 中国全科医学, 2018, 21(33): 4149-4156.
|
[39] |
刘雨辉, 卜先乐, 马辛, 等. 阿尔茨海默病药物治疗指南[J]. 阿尔茨海默病及相关病杂志, 2025, 8(1): 8-16.
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
中华医学会神经病学分会痴呆与认知障碍学组. 阿尔茨海默病源性轻度认知障碍诊疗中国专家共识2024[J]. 中华神经科杂志, 2024, (7): 715-737.
|
[45] |
|
[46] |
|
[47] |
李孟媛, 孙锦平, 孙伟, 等. 复方苁蓉益智胶囊治疗轻中度阿尔茨海默病患者的临床疗效研究[J]. 北京中医药大学学报, 2024, 47(8): 1145-1151.
|
[48] |
刘长宁, 张立娟, 侯翰如, 等. 中成药治疗阿尔茨海默病的网状Meta分析[J]. 中草药, 2022, 53(19): 6123-6138.
|
[49] |
赵克武, 张宁, 董晓红, 等. 补阳还五汤防治阿尔茨海默病的研究进展[J]. 中草药, 2024, 55(8): 2843-2852.
|
[50] |
|
[51] |
|
[52] |
梁玉晓, 齐婧. 天智颗粒联合盐酸多奈哌齐对阿尔茨海默病患者认知功能及生活质量的影响[J]. 河南医学研究, 2021, 30(5): 923-925.
|
[53] |
赖福生, 焦冬生, 卢少军, 等. 多奈哌齐联合天智颗粒治疗轻中度阿尔茨海默病的临床研究[J]. 中国实用神经疾病杂志, 2014, 17(10): 23-25.
|
[54] |
何瑛琨, 李士杰, 常玉娟, 等. 黄连解毒汤对阿尔茨海默症患者认知功能及血清Aβ1-42、BK表达的影响观察[J]. 中华中医药学刊: 1-8.
|
[55] |
|
[56] |
姜文, 田华, 胡洁玲, 等. 靳三针法联合健脑散对阿尔茨海默病患者脑血流的影响[J]. 江西中医药, 2018, 49(8): 51-53.
|
[57] |
|
[58] |
方伯言, 王丽, 闫天翼, 等. 无创神经调控技术辅助阿尔茨海默病治疗的中国专家共识[J]. 中国神经免疫学和神经病学杂志, 2023, 30(6): 387-394.
|
[59] |
|
[60] |
|
[61] |
|
[62] |
|
[63] |
|
[64] |
|
[65] |
|
[66] |
|
[67] |
中国微循环学会神经变性病专委会, 中华医学会神经病学分会神经心理与行为神经病学学组, 中华医学会神经病学分会神经康复学组. 阿尔茨海默病康复管理中国专家共识(2019)[J]. 中华老年医学杂志, 2020, 39(1): 9-19.
|
[68] |
|
[69] |
|
[70] |
|
[71] |
|
[72] |
|
[73] |
|
[74] |
|
[75] |
|
[76] |
|
[77] |
|
[78] |
|
[79] |
|
[80] |
|
[81] |
|
[82] |
|
[83] |
|
[84] |
|
[85] |
|
[86] |
|
[87] |
|
[88] |
|
[89] |
|
[90] |
|
[91] |
|
[92] |
|
[93] |
|
[94] |
|
[95] |
|
[96] |
|
[97] |
|
[98] |
|
[99] |
|
[100] |
|
[101] |
|
[102] |
|
[103] |
|
[104] |
|
[105] |
|
[106] |
|
[107] |
|
[108] |
|
[109] |
|
[110] |
|
[111] |
|
[112] |
|
[113] |
|
[114] |
|
[115] |
|
[116] |
|
[117] |
|
[118] |
|
[119] |
|
[120] |
|
[121] |
|
[122] |
|
[123] |
|
[124] |
|
[125] |
|
[126] |
|
[127] |
|
[128] |
|
[129] |
|
[130] |
|
[131] |
|
[132] |
|
[133] |
|
[134] |
|
[135] |
|
[136] |
|
[137] |
|
志谢:感谢以下人员对本共识所做出的贡献(按姓氏笔画排列)
专家组成员:于恩彦(浙江省肿瘤医院)、王永军(深圳市康宁医院)、王任直(香港中文大学深圳医学院)、王宝兰(新疆医科大学第一附属医院)、王慧芳(同济大学附属养志康复医院)、白玉龙(复旦大学附属华山医院)、吕泽平(国家康复辅具研究中心附属康复医院)、刘晓蕾(昆明医科大学第一附属医院)、刘浩(美国路易斯安娜州立大学)、刘敏(山东省立第三医院)、江柏轩(香港大学)、李浩(中国中医科学院西苑医院)、肖卫忠(北京大学第三医院)、沈璐(中南大学湘雅医院)、张通(中国康复研究中心)、张璐(郑州大学第一附属医院)、张巍(北京天坛医院)、顾平(河北医科大学第一医院)、徐群(上海交通大学医学院附属仁济医院)、黄微(云南省第三人民医院)
患者家属:杨秀珍(广东省广州市)、于占平(山东省烟台市)
执笔人:董军涛(深圳大学附属南山医院)、厉含之(中国康复研究中心)
秘书组:贾云晓(深圳大学附属南山医院)、高凡斯(深圳大学附属南山医院)
利益冲突声明:所有作者在本研究中均不存在利益冲突。
/
〈 |
|
〉 |